Hubert Beekhuizen

Hubert Beekhuizen is the Global Commercial Biosimilar Director at Pfizer, a position held since 2022. Previously, Hubert has held various roles within Pfizer, including Customer Strategy Manager for Oncology Biosimilars and Senior Manager of Customer Facing Skills. With extensive experience in training and development, Hubert has led numerous global training initiatives across regions such as Europe, North America, and Asia. Hubert's early career included roles at Roche Pharmaceuticals, where impactful management of sales teams and business planning contributed to professional growth and development. Hubert holds a BA from The Hague University of Applied Sciences.